DUALKOPT Σλοβακία - Σλοβακικά - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dualkopt

laboratoires thea, francúzsko - timolol, kombinácie - 64 - ophthalmologica

Pylera 140 mg/125 mg/125 mg tvrdé kapsuly Σλοβακία - Σλοβακικά - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pylera 140 mg/125 mg/125 mg tvrdé kapsuly

laboratoires juvise pharmaceuticals, francúzsko - subcitrónan bizmutitý, tetracyklín a metronidazol - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)

Dzuveo Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

dzuveo

laboratoire aguettant - sufentanil citrát - bolesť - anestetiká - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.

Labazenit Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

labazenit

laboratoires smb s.a.   - budesonide, salmeterol - astma - treatment of asthma.

Detralex 1000 mg perorálna suspenzia vo vrecku Σλοβακία - Σλοβακικά - ŠÚKL (Štátny ústav pre kontrolu liečiv)

detralex 1000 mg perorálna suspenzia vo vrecku

les laboratoires servier, francúzsko - diozmín, kombinácie - 85 - venopharmaca, antivaricosa

Cevenfacta Ευρωπαϊκή Ένωση - Σλοβακικά - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemoragiká - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.